Stocks
Gossamer Bio (GOSS) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -178.9 | -207.3 | -214.5 | -215.4 | -172.2 | -62.5 | ||
| Changes by years, y/y, % | +84% | +16% | +3% | +0% | -20% | +12.2% | |||
Gossamer Bio. EBITDA US GAAP, bln rub
Gossamer Bio. EBITDA US GAAP, changes, %
Gossamer Bio. EBITDA US GAAP, sum by quarters, bln rub
Gossamer Bio (GOSS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -37.9 | -35.6 | -38.0 | -42.0 | 53.1 | -62.5 | |
| Changes by years, y/y, % | -27% | -35% | -27% | -8% | -240% | |||
| Changes by quarters, q/q, % | -17% | -6% | +7% | +10% | -227% | |||
